The value and effectiveness of angiogenesis inhibitors for colorectal cancer
Venook, A.P.; Venook, A.P.
Clinical Advances in Hematology and Oncology H&o 13(9): 561-563
2015
ISSN/ISBN: 1543-0790 PMID: 26452184 Document Number: 684024
Document emailed within 1 workday
Related Documents
Dredge, K.; Dalgleish, A.G.; Marriott, J.B. 2003: Angiogenesis inhibitors in cancer therapy Current Opinion in Investigational Drugs 4(6): 667-674Li, W.W.; Li, V.W.; Brainerd, N.; Fagen, S.J. 2002: Global development of angiogenesis inhibitors for cancer: principles, progress and new paradigms Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(Suppl 1): 50-58
Christofferson, R. 1998: Angiogenesis inhibitors in advanced cancer. many current clinical trials show promising results Lakartidningen 95(20): 2349-2354
McKinnon, C. 1999: Prostate cancer, biological therapy, signal transduction inhibitors and anti-angiogenesis agents Idrugs: the Investigational Drugs Journal 2(7): 624-628
Lind, J.S.W.; Herder, G.J.M.; Smit, E.F. 2008: New therapies for the treatment of advanced non-small cell lung cancer: inhibitors of the epidermal growth factor receptor and angiogenesis Nederlands Tijdschrift Voor Geneeskunde 152(16): 928-932
Rothenberg, M.L.; Blanke, C.D. 1999: Topoisomerase i inhibitors in the treatment of colorectal cancer Seminars in Oncology 26(6): 632-639
Cassidy, J. 2000: Thymidylate synthase inhibitors in colorectal cancer Seminars in Oncology 27(5 Suppl 10: 83-87
Ranger, G.Singh. 2014: Current concepts in colorectal cancer prevention with cyclooxygenase inhibitors Anticancer Research 34(11): 6277-6282
Wang, L.; Cai, S.-r.; Zhang, C.-h.; He, Y.-l.; Zhan, W.-h.; Wu, H.; Peng, J.-j. 2008: Effects of angiotensin converting enzyme inhibitors and angiotensin Ii receptor blockers on angiogenesis of gastric cancer in a nude mouse model Zhonghua Wei Chang Wai Ke Za Zhi 11(6): 565-568
Malila, N.; Anttila, A.; Elovainio, L.; Hakulinen, T.; Järvinen, H.; Paimela, H.; Pikkarainen, P.; Rautalahti, M.; Hakama, M. 2003: Screening of colorectal cancer in Finland and analysis of its cost-effectiveness Duodecim; Laaketieteellinen Aikakauskirja 119(12): 1115-1123
Schrag, D.; Weeks, J. 1999: Costs and cost-effectiveness of colorectal cancer prevention and therapy Seminars in Oncology 26(5): 561-568
Ishiguro, M.; Sugihara, K.; Ishikawa, T.; Uetake, H. 2011: Perspective on cost-effectiveness analysis of chemotherapy for colorectal cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 3): 589-593
Thiéfin, Gérard.; Dupont, Aélie.; Guillou, P-José.; Vitry, F.; Bouche, O.; Yaziji, N.; Lagarde, Séphanie.; Maquart, Fçois-Xavier.; Palot, J-Pierre.; Hornebeck, W.; Diebold, M-Danièle. 2007: Beneficial influence of microsatellite instability on gelatinase-tissue inhibitors of metalloproteinase balance in colorectal cancer Anticancer Research 27(1b): 583-588
Biggs, C.G.; Ballantyne, G.H. 1994: Sensitivity versus cost effectiveness in postoperative follow-up for colorectal cancer Current Opinion in General Surgery 1994: 94-102
Bordin, D.S.; Masharova, A.A.; Lazebnik, L.B. 2008: Long-term therapy of acid-dependent diseases with proton pump inhibitors and risk of colorectal cancer (literature review) Eksperimental'naia i Klinicheskaia Gastroenterologiia 2008(4): 36-38
Shibuya, M. 2012: Tumor angiogenesis and its inhibitors Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 8): 149-153
Fiedler, W.; Staib, P.; Kuse, R.; Dührsen, U.; Flasshove, M.; Cavalli, F.; Hossfeld, D.K.; Berdel, W.E. 2001: Role of angiogenesis inhibitors in acute myeloid leukemia Cancer Journal 7(Suppl 3): S129-S133
Giles, F.J. 2002: The emerging role of angiogenesis inhibitors in hematologic malignancies Oncology 16(5 Suppl 4: 23-29
Maeshima, Y.; Makino, H. 2010: The role of pro-angiogenic factors and angiogenesis inhibitors in diabetic nephropathy Nihon Rinsho. Japanese Journal of Clinical Medicine 68(Suppl 9): 396-400
Reardon, D.A. 2014: Update on the use of angiogenesis inhibitors in adult patients with brain tumors Clinical Advances in Hematology and Oncology: H&o 12(5): 293-303